Opiant Pharma (OPNT) PT Lowered to $41 at Oppenheimer
Tweet
Share
E-mailGet Alerts OPNT Hot Sheet
Price: $20.65 --0%
Rating Summary:
0 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
0 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell lowered the price target on Opiant Pharma (NASDAQ: OPNT) to $41.00 (from $42.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $83 at Stifel
- HSBC Downgrades Anglo American Platinum Limited (AMS:SJ) (ANGPY) to Reduce
- Compass Minerals International (CMP) PT Lowered to $15 at Deutsche Bank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
